035: MAPS to Move Ahead with Phase 3 MDMA Trials

F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients – NY Times, Nov 29, 2016 “It changed my life.” It allowed me to see my trauma without fear or hesitation and finally process things and move forward." – study participant Ed Thompson “There is now a clear path ahead to make MDMA a legal medicine for millions of people suffering from PTSD.” – MAPS Bulletin MAPS needs to raise approximately $25-30 million (of which they’ve already raised more than $10 million) to complete these Phase 3 trials and all associated toxicity and pharmacology studies over the next 5 years. – NY Times MAPS.org